-
1 Comment
Jilin Zixin Pharmaceutical Industrial Co.,Ltd is currently in a long term downtrend where the price is trading 14.7% below its 200 day moving average.
From a valuation standpoint, the stock is 32.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.8.
Jilin Zixin Pharmaceutical Industrial Co.,Ltd's total revenue sank by 45.6% to $79M since the same quarter in the previous year.
Its net income has dropped by 1935.0% to $-63M since the same quarter in the previous year.
Finally, its free cash flow fell by 90.9% to $8M since the same quarter in the previous year.
Based on the above factors, Jilin Zixin Pharmaceutical Industrial Co.,Ltd gets an overall score of 0/5.
| ISIN | CNE000001R43 |
|---|---|
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| CurrencyCode | CNY |
| Exchange | SHE |
| Dividend Yield | 0.0% |
|---|---|
| Market Cap | 2B |
| PE Ratio | None |
| Target Price | 12.88 |
| Beta | 0.49 |
Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China. It provides ginseng drugs, prescription drugs, and OTC drugs. The company offers its products in the form of pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, and lozenges. Jilin Zixin Pharmaceutical Industrial Co.,Ltd was founded in 1998 and is based in Changchun, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002118.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
